2361 - Timing of antiretroviral therapy prior to diagnosis of cryptococcal meningitis

Presenting Author(s)

• 

  Bickey Chang, MD, MHA

  Resident
  University of Minnesota
  St Paul, MN, United States

  Disclosure: Disclosure(s): No financial relationships to disclose

  Slides

Co-Author(s)

• AW

  Abduljewad Wele, MS

  University of Minnesota
  Minnapolis, Minnesota, United States

  Disclosure: Disclosure(s): No financial relationships to disclose
• BA

  Bethlehem Atoma, MD

  University of Minnesota
  Minneapolis, Minnesota, United States

  Disclosure: Disclosure(s): No financial relationships to disclose
• EK

  Enock Kagimu, MBChB

  Infectious Diseases Institute, Makerere University
  kampala, Kampala, Uganda

  Disclosure: Disclosure(s): No financial relationships to disclose
• CM

  Conrad Muzoora, MBChB, MMed

  Mbarara University of Science and Technology
  Mbarara, Mbarara, Uganda

  Disclosure: Disclosure(s): No financial relationships to disclose
• AM

  Abdu Musubire, MBChB, MMed

  Infectious Diseases Institute, Makerere University
  Kampala, Kampala, Uganda

  Disclosure: Disclosure(s): No financial relationships to disclose
• 

  David R. Boulware, MD, MPH, CTropMed

  Professor
  University of Minnesota
  Minneapolis, Minnesota, United States

  Disclosure: Disclosure(s): No financial relationships to disclose
• DM

  David Meya, MBChB, MMed, PhD

  Principal Investigator
  Infectious Diseases Institute, Makerere University
  Kampala, Kampala, Uganda

  Disclosure: Disclosure(s): No financial relationships to disclose